DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes

Angelo J. Canty | J. Keith Jones | A. Paterson | S. Mudaliar | R. Avery | M. Budoff | B. Zinman | L. Aiello | P. Arrigg | S. Bull | P. Raskin | R. Klein | D. Bluemke | I. D. de Boer | J. Soule | L. Hubbard | A. Bhan | J. Albers | S. Strowig | B. Doft | L. Lobes | S. Feman | R. Rizza | I. Hramiak | J. Selby | L. Snetselaar | S. Ajroud‐Driss | D. Kruger | E. Soliman | T. Murtha | S. Hazen | J. Cavallerano | L. M. Aiello | J. Bantle | D. Lackland | R. Sussman | L. Jovanovič | E. Turkbey | E. Chaum | W. Tamborlane | N. White | R. Danis | S. Gangaputra | M. Mech | W. Herman | S. Engel | R. Prineas | D. O'leary | C. McDonald | R. Cuddihy | S. Genuth | A. Kitabchi | R. J. van der Geest | L. Zhang | C. Cowie | L. van Ottingham | J. Stoner | B. Chavers | D. Nathan | L. Delahanty | J. Lachin | P. Cleary | O. Crofford | M. Davis | L. Rand | C. Siebert | H. Shamoon | A. Karger | T. Lyons | R. Carter | D. Kendall | E. Feldman | B. French | M. Steffes | T. Songer | T. Orchard | D. Becker | A. Drash | K. Cruickshanks | D. Finegold | R. Natarajan | L. Luttrell | R. Mayfield | A. Jaffa | A. Vella | M. Bryer-Ash | I. Bebu | W. Garvey | K. McVary | W. Sun | R. Pop-Busui | R. Crow | M. Burge | D. Schade | A. Brucker | J. Kinyoun | A. Jacobson | D. Cros | A. Boright | H. Wabers | C. O'Donnell | R. Rizza | N. Rodger | L. Jampol | M. Molitch | W. Sivitz | F. Leandre | J. Hotaling | J. Brunzell | H. Lambeth | D. Brillon | J. Purnell | O. Ganda | D. Finegold | F. Goetz | J. Pach | M. Lopes-Virella | F. Thoma | P. Crawford | L. Ketai | S. Schwartz | B. Perkins | T. Weingeist | F. Miao | M. Palmert | R. Detrano | S. Engel | J. Malone | T. Donner | O. Kolterman | J. Godine | F. Service | P. Callahan | J. Colwell | D. Roshandel | Zhuoyou Chen | S. F. L. J. J. H. S. H. M. M. H. J. R. J. L. D. A. M. Scherer Miao Zhang Brown-Friday Crandall Engel | S. Scherer | L. Zhang | J. Brown-Friday | J. Crandall | H. Engel | H. Martinez | M. Phillips | M. Reid | J. Sheindlin | R. Gubitosi-Klug | J. Wood | L. Mayer | D. Miller | A. Nayate | M. Novak | S. Pendegast | L. Singerman | D. Weiss | H. Zegarra | E. Brown | P. Pugsley | J. Quin | S. Smith-Brewer | W. Dahms | J. McConnell | C. Beck | K. Farrell | P. Gastón | R. Trail | V. Monnier | D. Sell | C. Strauch | N. S. Gregory | R. Hanna | R. Chan | S. Kiss | A. Orlin | M. Rubin | S. Barron | B. Bosco | S. Chang | A. Dwoskin | M. Heinemann | L. Jovanovic | M. E. Lackaye | T. Lee | B. Levy | V. Reppucci | M. Richardson | R. Campbell | P. A. Edwards | H. Remtema | E. Angus | A. Galprin | M. McLellan | A. Thomas | J. Carey | F. Whitehouse | R. Bergenstal | S. Dunnigan | K. Gunyou | M. Johnson | A. Carlson | L. Thomas | R. Birk | G. Castle | M. Franz | D. Freking | L. Gill | J. Gott | P. Hollander | J. Laechelt | S. List | W. Mestrezat | J. Nelson | B. Olson | N. Rude | M. Spencer | D. Etzwiler | K. Morgan | E. Golden | R. Beaser | L. Bestourous | R. Cavicchi | O. Hamdy | D. Schlossman | S. Shah | G. Sharuk | P. Silva | P. Silver | M. Stockman | J. Sun | E. Weimann | V. Asuquo | R. Kirby | J. Rosenzwieg | H. Wolpert | M. Larkin | M. Cayford | A. de Manbey | L. Gurry | J. Heier | A. Joseph | K. Martin | C. Shah | C. Stevens | N. Thangthaeng | E. Anderson | H. Bode | S. Brink | M. Christofi | C. Cornish | S. Crowell | K. Folino | S. Fritz | C. Gauthier‐Kelly | C. Haggan | K. Hansen | P. Lou | J. Lynch | C. McKitrick | D. Moore | D. Norman | M. Ong | E. Ryan | C. Taylor | D. Zimbler | G. Ziegler | A. Barkmeier | M. Haymond | J. Mortenson | L. Schmidt | W. Schwenk | R. Woodwick | R. Colligan | A. Lucas | B. Zimmerman | K. Nickander | P. Low | C. Sommer | L. Spillers | J. Fernandes | K. Hermayer | S. Kwon | K. Lee | M. Nutaitis | A. Blevins | M. Bracey | S. Caulder | S. Elsing | A. Farr | D. Lee | P. Lindsey | J. Parker | N. Patel | C. Pittman | M. Szpiech | T. Thompson | D. Wood | S. Yacoub-Wasef | A. Jenkins | G. Virella | A. Jaffa | M. Brabham | D. McGee | D. Zheng | A. Wallia | D. Adelman | M. Hartmuller | P. Astelford | A. Degillio | M. Gill | C. Johnson | L. Kaminski | N. Leloudes | A. Lyon | R. Mirza | D. Ryan | E. Simjanoski | Z. Strugula | S. Colson | B. Schaefer | G. Lorenzi | M. Goldbaum | T. Clark | M. Giotta | I. Grant | K. Jones | R. Lyon | M. Prince | R. Reed | M. Swenson | G. Friedenberg | B. Vittetoe | J. Kramer | M. Bayless | C. Fountain | R. Hoffman | J. MacIndoe | N. Olson | H. Schrott | R. Zeitler | R. Miller | S. Johnsonbaugh | M. Carney | D. Counts | J. Gordon | M. Hebdon | R. Hemady | B. Jones | A. Kowarski | R. Liss | S. Mendley | D. Ostrowski | M. Patronas | P. Salemi | S. Steidl | C. Martin | P. Lee | D. Greene | M. Stevens | N. Burkhart | T. Sandford | J. Floyd | A. Sarma | R. Dunn | T. Speigelberg | N. Flaherty | D. Koozekanani | S. Montezuma | J. Terry | C. Kwong | L. McKenzie | J. Olson | B. Rogness | T. Strand | R. Warhol | N. Wimmergren | A. Karger | J. Seegmiller | V. Arends | J. Bucksa | A. Killeen | M. Nowicki | A. Saenger | B. Gloeb | S. Thomas | D. Goldstein | D. Hainsworth | S. Hitt | J. Giangiacomo | J. Canady | J. Chapin | A. Das | D. Hornbeck | C. Johannes | J. Rich | M. L. Schluter | M. Schutta | P. A. Bourne | S. Braunstein | B. J. Maschak-Carey | L. Baker | L. Cimino | D. Rubinstein | K. Kelly | N. Silvers | D. Steinberg | L. Steranchak | J. Wesche | C. Ryan | B. Burzuk | E. Cupelli | M. Geckle | D. Sandstrom | T. Williams | T. Woodfill | A. Morrison | M. Bernal | P. Pavan | L. Babbione | T. Declue | N. Grove | D. Mcmillan | H. Solc | E. Tanaka | J. Vaccaro‐Kish | S. Dagogo-Jack | C. Wigley | S. Huddleston | A. Patel | A. Iannacone | D. Meyer | S. Moser | M. Murphy | H. Ricks | S. Schussler | S. Yoser | Y. G. He | E. Mendelson | R. Ufret-Vincenty | M. Basco | S. Cercone | L. Sun | A. Barnie | N. Bakshi | M. Brent | R. Devenyi | K. Koushan | M. Mandelcorn | F. Perdikaris | L. Tuason | D. Daneman | R. Ehrlich | S. Ferguson | A. Gordon | K. Perlman | S. Rogers | J. Palmer | R. Fahlstrom | L. O. de Koo | S. Catton | J. Ginsberg | H. Wessells | S. Holt | C. Kim | Q. Clemens | J. Brown | M. Driscoll | J. Bylsma | T. Sheidow | W. Brown | C. Canny | P. Colby | S. Debrabandere | J. Dupré | J. Harth | M. Jenner | J. Mahon | D. Nicolle | T. Smith | M. May | J. Hagan | R. Ramker | T. Adkins | A. Agarwal | C. Lovell | R. Lorenz | L. Survant | L. Levandoski | I. Boniuk | J. Santiago | P. Gatcomb | K. Stoessel | J. Ahern | K. Fong | P. Ossorio | P. Ramos | B. Braffett | J. Backlund | L. Diminick | X. Gao | D. Kenny | K. Klumpp | M. Lin | V. Trapani | K. Anderson | K. Chan | A. Determan | L. Dews | W. Hsu | P. McGee | H. Pan | B. Petty | D. Rosenberg | B. Rutledge | S. Villavicencio | N. Younes | C. Williams | A. Harrington | J. Polak | L. Funk | M. Barr | C. Campbell | S. Hensley | J. Hu | L. Keasler | Y. Li | T. Taylor | Z. Zhang | B. Blodi | D. Lawrence | M. Burger | J. Dingledine | V. Gama | S. Neill | D. Dalton | K. Bainbridge | S. Darabian | P. Rezaeian | M. Fox | L. Kim | R. Oudiz | N. Wong | J. Lima | H. Chahal | A. Jain | R. Jarboe | C. Liu | A. Malayeri | C. Miao | A. Pratt | W. Tang | J. Maynard | J. Farquhar | M. Moran | M. Pfiefer | M. Schumer | J. Ahern | P. Crawford | B. Rutledge | R. Klein | D. Zheng | D. Lackland | P. Pavan | D. Bluemke | S. Schwartz | A. Farr | M. Mech | L. Luttrell | L. Cimino | J. Lynch | P. Raskin | R. Danis | M. Bryer‐Ash | S. Hazen | J. Purnell | D. Counts | D. Schade | P. Hollander | S. Shah | X. Gao | D. Miller | M. Lin | F. Léandre | D. Miller | C. Kim | J. Hu | M. Heinemann | M. Prince | D. O’Leary | A. Sarma | E. Z. Soliman | D. Hainsworth | J. Selby | R. Sussman | A. Vella | S. Dagogo-Jack | H. Ricks | C. Johannes | B. Doft | M. Brent | A. D. Paterson | L. Aiello | C. O’Donnell | H. Pan | A. Saenger | M. Steffes | R. Crow | J. Stoner | Zhuo Chen | S. F. L. J. J. H. S. H. M. M. H. J. R. J. L. D. A. M. Scherer Miao Zhang Brown-Friday Crandall Engel | J. Wood | A. Nayate | M. Novak | S. Chang | A. Bhan | M. Johnson | D. Kendall | A. Jacobson | R. Kirby | M. Larkin | H. Bode | S. Brink | S. Crowell | C. Gauthier-Kelly | W. Schwenk | A. Blevins | J. Colwell | R. Mayfield | N. Patel | J. Soule | R. Carter | L. Jampol | S. Mudaliar | M. Carney | R. Liss | C. L. Martin | D. A. Greene | T. Sandford | J. Floyd | J. Bantle | M. Nowicki | C. O’Donnell | A. Brucker | D. Becker | L. Lobes | F. Thoma | T. Williams | J. Vaccaro-Kish | C. Wigley | L. Sun | R. Ehrlich | K. Perlman | J. Kinyoun | H. Wessells | J. Hotaling | J. Brown | J. Dupré | J. Mahon | T. Smith | J. Hagan | C. Lovell | R. Lorenz | N. White | X. Gao | N. Younes | C. Cowie | C. Siebert | T. Taylor | K. Bainbridge | M. Budoff | J. Farquhar | L. Jovanović | M. Johnson | M. Johnson | Y. He | S. Ajroud-Driss | M. Budoff

[1]  J. Albers,et al.  Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study , 2020, Diabetes.

[2]  A. Paterson,et al.  Early Glomerular Hyperfiltration and Long-Term Kidney Outcomes in Type 1 Diabetes: The DCCT/EDIC Experience. , 2019, Clinical journal of the American Society of Nephrology : CJASN.

[3]  Shriji N. Patel,et al.  Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study , 2019, Diabetes Care.

[4]  A. Paterson,et al.  Risk Factors for Kidney Disease in Type 1 Diabetes , 2019, Diabetes Care.

[5]  J. Lachin,et al.  Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study , 2019, Diabetes Care.

[6]  Alex P. Reiner,et al.  DNA methylation GrimAge strongly predicts lifespan and healthspan , 2019, Aging.

[7]  J. Kaprio,et al.  Leisure-time physical activity and DNA methylation age—a twin study , 2019, Clinical Epigenetics.

[8]  S. Horvath,et al.  Tracking the Epigenetic Clock Across the Human Life Course: A Meta-analysis of Longitudinal Cohort Data , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.

[9]  Shijie C. Zheng,et al.  Cell and tissue type independent age-associated DNA methylation changes are not rare but common , 2018, bioRxiv.

[10]  Alex P. Reiner,et al.  Epigenetic clock for skin and blood cells applied to Hutchinson Gilford Progeria Syndrome and ex vivo studies , 2018, Aging.

[11]  George Davey Smith,et al.  Meffil: efficient normalization and analysis of very large DNA methylation datasets , 2018, Bioinform..

[12]  M. Levine,et al.  An epigenetic biomarker of aging for lifespan and healthspan , 2018, bioRxiv.

[13]  N. Roetker,et al.  Prospective Study of Epigenetic Age Acceleration and Incidence of Cardiovascular Disease Outcomes in the ARIC Study (Atherosclerosis Risk in Communities) , 2018, Circulation. Genomic and precision medicine.

[14]  Angelo J. Canty,et al.  Meta-genome-wide association studies identify a locus on chromosome 1 and multiple variants in the MHC region for serum C-peptide in type 1 diabetes , 2018, Diabetologia.

[15]  A longitudinal study of DNA methylation as a potential mediator of age-related diabetes risk , 2017, GeroScience.

[16]  W. Milberg,et al.  The correlation of methylation levels measured using Illumina 450K and EPIC BeadChips in blood samples , 2017, Epigenomics.

[17]  T. Lehtimäki,et al.  Obesity accelerates epigenetic aging in middle-aged but not in elderly individuals , 2017, Clinical Epigenetics.

[18]  M. Levine,et al.  An epigenetic clock analysis of race/ethnicity, sex, and coronary heart disease , 2016, Genome Biology.

[19]  A. Keech,et al.  Shorter telomeres in adults with Type 1 diabetes correlate with diabetes duration, but only weakly with vascular function and risk factors. , 2016, Diabetes research and clinical practice.

[20]  H. Brenner,et al.  Epigenetic age acceleration predicts cancer, cardiovascular, and all-cause mortality in a German case cohort , 2016, Clinical Epigenetics.

[21]  Dustin E. Schones,et al.  Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort , 2016, Proceedings of the National Academy of Sciences.

[22]  C. Cowie,et al.  Risk Factors for Cardiovascular Disease in Type 1 Diabetes , 2016, Diabetes.

[23]  B. Shields,et al.  A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults , 2015, Diabetes Care.

[24]  D. Faustman,et al.  Low levels of C‐peptide have clinical significance for established Type 1 diabetes , 2015, Diabetic medicine : a journal of the British Diabetic Association.

[25]  T. Battelino,et al.  Association of Average Telomere Length with Body-Mass Index and Vitamin D Status in Juvenile Population with Type 1 Diabetes , 2015, Zdravstveno varstvo.

[26]  Manolis Kellis,et al.  Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers , 2015, Nature Genetics.

[27]  Steve Horvath,et al.  Obesity accelerates epigenetic aging of human liver , 2014, Proceedings of the National Academy of Sciences.

[28]  N. White,et al.  Effect of Intensive Diabetes Therapy on the Progression of Diabetic Retinopathy in Patients With Type 1 Diabetes: 18 Years of Follow-up in the DCCT/EDIC , 2014, Diabetes.

[29]  Y. Tomer,et al.  DNA methylation profiles in type 1 diabetes twins point to strong epigenetic effects on etiology. , 2014, Journal of autoimmunity.

[30]  J. Lachin,et al.  Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial , 2014, Diabetes.

[31]  B. Zinman,et al.  Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study. , 2014, The lancet. Diabetes & endocrinology.

[32]  Raivo Kolde,et al.  DNA methylome profiling of human tissues identifies global and tissue-specific methylation patterns , 2014, Genome Biology.

[33]  S. Horvath.  DNA methylation age of human tissues and cell types , 2013, Genome Biology.

[34]  F. Pociot,et al.  Residual β-Cell Function 3–6 Years After Onset of Type 1 Diabetes Reduces Risk of Severe Hypoglycemia in Children and Adolescents , 2013, Diabetes Care.

[35]  A. Girling,et al.  Effects of physical activity on the development and progression of microvascular complications in type 1 diabetes: retrospective analysis of the DCCT study , 2013, BMC Endocrine Disorders.

[36]  T. Ideker,et al.  Genome-wide methylation profiles reveal quantitative views of human aging rates. , 2013, Molecular cell.

[37]  Devin C. Koestler,et al.  DNA methylation arrays as surrogate measures of cell mixture distribution , 2012, BMC Bioinformatics.

[38]  Mark E Molitch,et al.  Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. , 2011, The New England journal of medicine.

[39]  C. Forsblom,et al.  Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study , 2011, BMJ : British Medical Journal.

[40]  Steve Horvath,et al.  Epigenetic Predictor of Age , 2011, PloS one.

[41]  Thomas A. Down,et al.  Identification of Type 1 Diabetes–Associated DNA Methylation Variable Positions That Precede Disease Diagnosis , 2010, PLoS genetics.

[42]  C. Forsblom,et al.  Telomere length and progression of diabetic nephropathy in patients with type 1 diabetes , 2010, Journal of internal medicine.

[43]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[44]  H. Parving,et al.  Telomere length predicts all-cause mortality in patients with type 1 diabetes , 2009, Diabetologia.

[45]  I-Min Lee,et al.  Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. , 2007, Medicine and science in sports and exercise.

[46]  Å. Lernmark,et al.  Antibodies to GAD65 and peripheral nerve function in the DCCT , 2007, Journal of Neuroimmunology.

[47]  S. Soedamah-Muthu,et al.  All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992–1999 , 2006, Diabetologia.

[48]  M. Steffes,et al.  Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial. , 2003, Diabetes care.

[49]  Adverse Events and Their Association With Treatment Regimens in the Diabetes Control and Complications Trial , 1995, Diabetes Care.

[50]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[51]  The Diabetes Control and Complications Trial (DCCT): Design and Methodologic Considerations for the Feasibility Phase , 1986, Diabetes.

[52]  The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group. , 1986, Diabetes.

[53]  S. Colagiuri,et al.  The Diabetes Control and Complications Trial , 1983, Henry Ford Hospital medical journal.